Status:
ACTIVE_NOT_RECRUITING
Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors
Lead Sponsor:
Vejle Hospital
Collaborating Sponsors:
Aarhus University Hospital
Centre for Oncology Education and Research Translation (CONCERT), Australia
Conditions:
Fear of Cancer Recurrence
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cognitive therapy has been shown to reduce fear of cancer recurrence (FCR), mainly in breast cancer survivors. The accessibility of cognitive behavioural interventions could be further improved by Int...
Detailed Description
Colorectal cancer (CRC) screening, early detection, and improved treatment have led to rising survival rates over the past decades. This improvement has resulted in an increasing number of long-term C...
Eligibility Criteria
Inclusion
- Completed curative intent colorectal cancer treatment with surgery and/or radiation and/or adjuvant chemotherapy between 1 March 2014 and 31 December 2018
- No history of recurrence after primary operation
- Fear of Cancer Recurrence Inventory score of 22 or above (14)
- Age 18 or above
- Reads and understands Danish
- Access and ability to use Internet
Exclusion
- Cancer recurrence at any follow-up
- Inability to comply with the protocol due to severe psychiatric, cognitive disorder or substance abuse identified during telephone interview
- As the intervention is web-based, participants without knowledge of or access to the Internet will be excluded from the RCT (including dyslexia).
Key Trial Info
Start Date :
May 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04287218
Start Date
May 10 2023
End Date
June 1 2026
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vejle Hospital, University Hospital of Southern Denmark
Vejle, Denmark, 7100